Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study

详细信息    查看全文

• 作者：Tiange Wang ; Yu Xu ; Min Xu ; Weiqing Wang ; Yufang Bi ; Jieli Lu…
• 关键词：Diabetes ; Hypertension ; Dyslipidemia ; Control ; China
• 刊名：Cardiovascular Diabetology
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：14
• 期：1
• 全文大小：613 KB
• 参考文献：1. Rosamond, W, Flegal, K, Friday, G, Furie, K, Go, A, Greenlund, K (2007) Heart disease and stroke statistics-007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: pp. e69-171 CrossRef
  2. Lawes, CM, Vander Hoorn, S, Rodgers, A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371: pp. 1513-8 CrossRef
  3. Lewington, S, Whitlock, G, Clarke, R, Sherliker, P, Emberson, J, Halsey, J (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: pp. 1829-39 CrossRef
  4. Zhang, X, Patel, A, Horibe, H, Wu, Z, Barzi, F, Rodgers, A (2003) Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 32: pp. 563-72 CrossRef
  5. Erqou, S, Kaptoge, S, Perry, PL, Angelantonio, E, Thompson, A, White, IR (2009) Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Jama 302: pp. 412-23 CrossRef
  6. Farzadfar, F, Finucane, MM, Danaei, G, Pelizzari, PM, Cowan, MJ, Paciorek, CJ (2011) National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377(: pp. 578-86 CrossRef
  7. Chow, CK, Teo, KK, Rangarajan, S, Islam, S, Gupta, R, Avezum, A (2013) Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Jama 310: pp. 959-68 CrossRef
  8. Tolonen, H, Keil, U, Ferrario, M, Evans, A (2005) Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol 34: pp. 181-92 CrossRef
  9. Goff, DC, Bertoni, AG, Kramer, H, Bonds, D, Blumenthal, RS, Tsai, MY (2006) Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113: pp. 647-56 CrossRef
  10. Joffres, M, Falaschetti, E, Gillespie, C, Robitaille, C, Loustalot, F, Poulter, N (2013) Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 3: pp. e003423 CrossRef
  11. Hogan, P, Dall, T, Nikolov, P (2003) Economic costs of diabetes in the US in 2002. Diabetes Care 26: pp. 917-32 CrossRef
  12. Xu, Y, Wang, L, He, J, Bi, Y, Li, M, Wang, T (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310: pp. 948-59 CrossRef
  13. Hoeven, KH, Factor, SM (1990) A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82: pp. 848-55 CrossRef
  14. Querton, L, Buysschaert, M, Hermans, MP (2012) Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. J Clin Lipidol 6: pp. 434-42 CrossRef
  15. Sowers, J
• 刊物主题：Diabetes; Angiology; Cardiology;
• 出版者：BioMed Central
• ISSN：1475-2840

文摘

Background The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18?years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.